期刊名称：International Journal of Advances in Engineering and Management
电子版ISSN：2395-5252
出版年度：2021
卷号：3
期号：3
页码：1005-1011
DOI：10.35629/5252-030311071110
语种：English
出版社：IJAEM JOURNAL
摘要：The Indian pharmaceuticals industry is the world’s third largest drug producer by volume. It is recognized globally due it the cost effectiveness and quality of the pharma products. A variety of medicines and vaccines are manufactured by the well-established industries of India. Moreover, the country’s market manufactures about 60% of vaccines globally. This constitutes 40-70% of supply to satisfy the World Health Organization’s demand for diseases like Diphtheria, Tetanus, Pertussis and 90% of the global demand for the Measles vaccine.During unprecedented times of Covid-19, pharmaceutical companies had to face rapid challenges arising from disruption in supply chains. But they strived hard for manufacturing the drugs and vaccines during the pandemic. Not only multinational companies but also the domestic players took an initiative of manufacturing life-saving drugs. They are competing globally in the market for both original and generic products. India is responsible for almost 8% of world pharmaceutical production. Innovative technologies and advance research strategy have been in the key role for the increase in demand of the Indian pharmaceuticals. It has also played a significant role in socio-economic development of the country by providing business, job opportunities and social benefits to the country. This review inculcates the evolution of pharmaceutical industry of India and also reflects the importance of the industry globally.
